JESSICA HILL: Open Payments
NPI 1427372788 · MARION, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,528 in 62 payments from 31 companies in 2025. Trend: 2023 $241 · 2024 $1,513 · 2025 $1,528
Food & beverage: $1,363Education: $165
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 9 | $254 |
| Novartis Pharmaceuticals Corporation | 7 | $160 |
| Genentech USA, Inc. | 4 | $123 |
| Merck Sharp & Dohme LLC | 4 | $93 |
| PFIZER INC. | 3 | $77 |
| ABBVIE INC. | 3 | $74 |
| GlaxoSmithKline, LLC. | 2 | $67 |
| Ipsen Biopharmaceuticals, Inc | 2 | $56 |
| Astellas Pharma US Inc | 2 | $54 |
| SERVIER PHARMACEUTICALS LLC | 2 | $46 |
Products named: PLUVICTO, KEYTRUDA, Itovebi, ZEJULA, Onivyde, IBRANCE, Tibsovo, BRUKINSA.
Industry payments across VA — which companies pay providers there.
